Eric M. Dube, Chief Executive Officer at Travere Therapeutics, Inc. (TVTX), sold 8,910 shares at $14.71 ($131K) on 2023-09-05, disclosed to the SEC on 2023-09-05.
Open-market sale of $131k TVTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.71 | 4,455 | $66K | 50.0% |
| 2 | $14.71 | 4,455 | $66K | 50.0% |
| Total | $14.71 avg | 8,910 | $131K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |